November 26, 2025 Human anti-chimeric antibodies (or HACA) may neutralise and obvious the antibody from your blood circulation, preventing it from reaching tumour sites and reducing efficacy; HACA, therefore, should be monitored and correlated with clinical readouts
May 1, 2025 Proof applicability was shown for just two therapeutic molecule classes and two relevant functional testing read-outs